Source comparison
Bepecin vs BPC-157: Name Comparison
The table below clarifies the naming, sourcing, and practical differences (or lack thereof) between Bepecin and BPC-157 across key research and procurement parameters. Amino-Acid Sequence Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val Identical 15
This comparison does not assign a generated winner or score.
- The table below clarifies the naming, sourcing, and practical differences (or lack thereof) between Bepecin and BPC-157 across key research and procurement parameters.
- Amino-Acid Sequence
- Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val
- Identical 15-amino-acid sequence—no structural difference
- Molecular Weight
- 1419.54 Da (acetate salt)
- Same molecular weight confirms identical compound
- Primary Geographic Source
- European suppliers (Switzerland, Germany, Poland)
- North American and Asian suppliers
- Regional branding—molecule unchanged
- Typical Purity Range
- 96–99.5% (HPLC verified)
- Purity depends on supplier tier, not name
- Common Research Applications
- Gastric protection, tissue repair, angiogenesis models
- Identical mechanisms and use cases
- Price Differential
- €85–120 per 5mg vial (European suppliers)
- $65–95 per 5mg vial (North American suppliers)
- 15–25% premium for European branding and logistics
- Regulatory Designation
- Registered trademark in EU; research-grade peptide
- Laboratory designation; research-grade peptide
- Neither is FDA-approved; both are research compounds
- Publications Referencing Name
- Proprietary supplier studies, limited peer-review
- 60+ PubMed-indexed publications since 1993
- BPC-157 dominates academic literature
- Storage Requirements
- −20°C lyophilized; 2–8°C reconstituted, use within 28 days
- Storage protocols identical for both
- Mechanism of Action
- FAK-paxillin activation, VEGF upregulation, NO modulation
- Same receptor binding and signaling pathways